LUMIRADX LTD (LMDX) Stock Price, Quote, News and Overview
NASDAQ:LMDX - Nasdaq - KYG5709L1095 - Common Stock - Currency: USD
LMDX Quote, Performance and Key Statistics
0.016
-0.02 (-53.49%)
The current stock price of LMDX is 0.016 USD. In the past month the price decreased by -84.1%. In the past year, price decreased by -98.21%.
LMDX Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 28.89 | 234.01B | ||
| ISRG | INTUITIVE SURGICAL INC | 80.74 | 211.07B | ||
| BSX | BOSTON SCIENTIFIC CORP | 41.63 | 154.00B | ||
| SYK | STRYKER CORP | 31.4 | 145.92B | ||
| MDT | MEDTRONIC PLC | 16.84 | 115.33B | ||
| BDX | BECTON DICKINSON AND CO | 16.35 | 65.30B | ||
| EW | EDWARDS LIFESCIENCES CORP | 27.98 | 43.23B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 20.29 | 41.62B | ||
| IDXX | IDEXX LABORATORIES INC | 40.25 | 37.07B | ||
| DXCM | DEXCOM INC | 53.81 | 34.68B | ||
| RMD | RESMED INC | 26.21 | 34.03B | ||
| PHG | KONINKLIJKE PHILIPS NVR- NY | 17.5 | 24.02B |
Related stock screener links
About LMDX
Company Profile
LumiraDX Ltd. is a next-generation point of care diagnostics company, which engages in the provision of an innovative diagnostic platform that supports a menu of tests with lab-comparable performance at the point of care. The firm is focused on transforming community-based healthcare by providing critical diagnostic information to healthcare providers at the point of need. The firm has developed and launched the LumiraDx Platform, which is an integrated system comprised of a small, versatile Instrument, low-cost microfluidic Test Strips, and seamless, secure digital connectivity. The firm offers a menu of lab comparable tests on a single portable platform, with more than 30 assays on the market and in various stages of development, covering infectious diseases, cardiovascular diseases, diabetes, and coagulation disorders. The company also supports laboratory testing in an accessible high-throughput format to leverage molecular laboratory operations. Its diagnostic testing solutions are being deployed globally by governments and healthcare institutions across laboratories, urgent care, physician offices, pharmacies, schools and others.
Company Info
LUMIRADX LTD
PO Box 1350, Windward 3, Regatta Office
George Town KY
CEO: Larry J. Neiterman
Employees: 1210
Company Website: https://www.lumiradx.com/
Phone: 13546400540
LUMIRADX LTD / LMDX FAQ
What is the stock price of LUMIRADX LTD today?
The current stock price of LMDX is 0.016 USD. The price decreased by -53.49% in the last trading session.
What is the ticker symbol for LUMIRADX LTD stock?
The exchange symbol of LUMIRADX LTD is LMDX and it is listed on the Nasdaq exchange.
On which exchange is LMDX stock listed?
LMDX stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for LUMIRADX LTD stock?
8 analysts have analysed LMDX and the average price target is 1.22 USD. This implies a price increase of 7550% is expected in the next year compared to the current price of 0.016. Check the LUMIRADX LTD stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is LUMIRADX LTD worth?
LUMIRADX LTD (LMDX) has a market capitalization of 2.63M USD. This makes LMDX a Nano Cap stock.
How many employees does LUMIRADX LTD have?
LUMIRADX LTD (LMDX) currently has 1210 employees.
Is LUMIRADX LTD (LMDX) expected to grow?
The Revenue of LUMIRADX LTD (LMDX) is expected to decline by -64.72% in the next year. Check the estimates tab for more information on the LMDX EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy LUMIRADX LTD (LMDX) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of LMDX, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of LMDX, evaluating the profitability, health, valuation and growth aspects
- LUMIRADX LTD (LMDX) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- LUMIRADX LTD (LMDX) Sales and EPS estimates to see what analysts future expectations are.
- LUMIRADX LTD (LMDX) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- LUMIRADX LTD (LMDX) Insider and Institutional Ownership to learn about the owners and their transactions.
- LUMIRADX LTD (LMDX) Stock Chart to make your own analysis
- LUMIRADX LTD (LMDX) Latest news and press-releases to stay up to date.
Does LUMIRADX LTD (LMDX) stock pay dividends?
LMDX does not pay a dividend.
When does LUMIRADX LTD (LMDX) report earnings?
LUMIRADX LTD (LMDX) will report earnings on 2024-03-19, after the market close.
What is the Price/Earnings (PE) ratio of LUMIRADX LTD (LMDX)?
LUMIRADX LTD (LMDX) does not have a PE ratio as the earnings reported over the last twelve months were negative (-1.09).
LMDX Technical Analysis
LMDX Fundamental Analysis
ChartMill assigns a fundamental rating of 1 / 10 to LMDX. Both the profitability and financial health of LMDX have multiple concerns.
LMDX Financial Highlights
Over the last trailing twelve months LMDX reported a non-GAAP Earnings per Share(EPS) of -1.09. The EPS increased by 1.8% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -99.18% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
LMDX Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 83% to LMDX. The Buy consensus is the average rating of analysts ratings from 8 analysts.
For the next year, analysts expect an EPS growth of 70.33% and a revenue growth -64.72% for LMDX